1. 2746 A Phase 2 open-label, multicenter study of single-agent rucaparib in the treatment of patients with relapsed ovarian cancer and a deleterious BRCA mutation. (September 2015) Authors: Shapira-Frommer, R.; Oza, A.; Domchek, S.M.; Balmana, J.; Patel, M.R.; Chen, L.M.; Drew, Y.; Burris, H.A.; Korach, J.; Flynn, M.; Bowering, V.L.; Morgan, M.A.; Watkins, S.P.; Simpson, D.; Goble, S.; Maloney, L.; Kristeleit, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Integrated efficacy and safety analysis of the poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with high-grade ovarian carcinoma (HGOC). (February 2017) Authors: Oaknin, A.; Oza, A.; Tinker, A.V.; Ray-Coquard, I.; Coleman, R.; O'Malley, D.; Shapira-Frommer, R.; Leary, A.; Chen, L.M.; Provencher, D.; Ma, L.; Brenton, J.; Balmaña, J.; Giordano, H.; Maloney, L.; Goble, S.; Rolfe, L.; McNeish, I.; Swisher, E.; Kristeleit, R.S. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. On the non-Fourier thermal fracture of an edge-cracked cylindrical bar. (December 2015) Authors: Chen, L.M.; Fu, J.W.; Qian, L.F. Journal: Theoretical and applied fracture mechanics Issue: Volume 80: Part B (2015) Page Start: 218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗